Country for PR: United States
Contributor: PR Newswire New York
Monday, June 19 2017 - 14:00
AsiaNet
Live MRI-Guided Ablation to be Featured at EHRA Europace-Cardiostim 2017
VIENNA, June 19, 2017 /PRNewswire-AsiaNet/ --

A special live case session at this year's EHRA Europace – Cardiostim 
conference will feature a real-time MRI-guided atrial ablation from the Helios 
Heart Center Leipzig using Imricor's Vision-MR(TM) Ablation Catheter and 
Advantage-MR(TM) EP Recorder/Stimulator System. The live case will be broadcast 
on Tuesday, June 20th at 11:00 am in the Senning Room of the Messe Wien 
conference center in Vienna, Austria.

Logo - 
https://mma.prnewswire.com/media/150501/imricor_medical_systems_inc_logo.jpg 

Each year, the EHRA Europace – Cardiostim conference highlights the latest in 
research and technology for cardiac rhythm disorders and therapies. This year's 
conference will feature four live cases; one of which being the MRI-guided 
ablation from Leipzig. This much-anticipated live case is being described as a 
"not to be missed" session by the EHRA Europace Cardiostim 2017 Scientific 
Chair, Prof. Michael Glikson, FESC.(1)

Cardiac ablations guided by real-time MRI offer several potential benefits over 
traditional x-ray guided procedures. With MRI guidance, physicians can 
individualize their treatment strategies by visualizing each patient's unique 
tissue structure and current disease state. In addition, MRI allows physicians 
to see the immediate results of the therapy they are delivering. This means 
that doctors can assess lesion quality and fill gaps in an ablation line during 
the initial procedure. As incomplete or inadequate ablation lines are believed 
to be the primary cause of arrhythmia recurrence, intra-procedural lesion 
visualization offers physicians a significant advantage in the treatment of 
cardiac disorders.

Caution: The Advantage-MR EP Recorder/Stimulator System has received CE mark 
approval; it has not yet been approved for use in the United States. The 
Vision-MR Ablation Catheter has been approved as an investigational device for 
clinical studies in Europe. All other Imricor products are not yet approved for 
use in humans.

About Imricor 
Imricor Medical Systems is a privately held company that specializes in 
developing medical devices and systems that are compatible with magnetic 
resonance imaging (MRI). Its unique MR-enabled products are designed to provide 
doctors the ability to perform interventional procedures while taking advantage 
of the superior soft tissue imaging of MRI. Imricor is the world leader in the 
development of MR-enabled catheters for electrophysiology applications. Imricor 
also licenses its technology to help make implanted medical devices compatible 
with MRI. For more information, visit www.imricor.com.

Imricor Medical Systems, Inc.
400 Gateway Blvd.
Burnsville, MN 55123

Contact:
Jodi Lamberti – Marketing Communications Manager
phone: +1-952-818-8417
E-mail: jodi.lamberti@imricor.com

(1) 
https://www.escardio.org/Congresses-&-Events/EHRA-Europace-Cardiostim/Congress-resources/whole-field-of-electrophysiology-is-covered


SOURCE  Imricor Medical Systems, Inc.